Mercer Island, WA, United States of America

Serguei Lejnine

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2010.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Osteoarthritis Risk Evaluation by Serguei Lejnine

Introduction

Serguei Lejnine is an accomplished inventor based in Mercer Island, WA (US). He has made significant contributions to the field of medical diagnostics, particularly in evaluating the risk of osteoarthritis (OA). His innovative methods aim to improve the diagnosis and management of this prevalent condition.

Latest Patents

Serguei Lejnine holds a patent for "Methods for evaluating osteoarthritis risk." This patent encompasses various methods for diagnosing OA, confirming diagnoses, assessing disease progression, determining severity, and evaluating the risk of developing OA in the future. The methods involve analyzing the activity of OA risk-related molecules, such as soluble vascular adhesion protein 1 (sVAP-1) and interleukin-15 (IL-15). Additionally, the patent includes methods for identifying compounds that can alter the activity of OA-related molecules, paving the way for potential anti-osteoarthritis drugs. He has 1 patent to his name.

Career Highlights

Serguei Lejnine is associated with the United States of America, as Represented by the Secretary, Department of Health and Human Services. His work focuses on advancing the understanding and treatment of osteoarthritis through innovative research and development.

Collaborations

Serguei collaborates with notable colleagues, including Velizar T Tchernev and Dhavalkumar D Patel. Their combined expertise contributes to the advancement of research in osteoarthritis and related fields.

Conclusion

Serguei Lejnine's innovative methods for evaluating osteoarthritis risk represent a significant advancement in medical diagnostics. His contributions have the potential to improve patient outcomes and enhance the understanding of this common condition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…